| Viatris Pharma GmbH - Influvac Tetra 0.5 ml, Injektionssuspension | | 68087 | | 05 | | Influvac Tetra 0.5 ml | | Injektionssuspension | | J07BB02 | | Influenza, gereinigtes Antigen | | 18.07.2025 | | |
| | Zusammensetzung | | haemagglutininum influenzae A (H1N1) (Virus-Stamm A/Victoria/4897/2022 (H1N1)-pdm09: reassortant virus IVR-238 derived from A/Victoria/4897/2022) 15 µg, haemagglutininum influenzae A (H3N2) (Virus-Stamm A/Croatia/10136RV/2023 (H3N2)-like: reassortant virus X-425A derived from A/Croatia/10136RV/2023) 15 µg, haemagglutininum influenzae B (Virus-Stamm B/Austria/1359417/2021 -like: reassortant virus BVR-26 derived from B/Austria/1359417/2021 (Victoria lineage)) 15 µg, haemagglutininum influenzae B (Virus-Stamm B/Phuket/3073/2013, wild type (Yamagata lineage)) 15 µg, kalii chloridum, kalii dihydrogenophosphas, dinatrii phosphas dihydricus, natrii chloridum, calcii chloridum dihydricum, magnesii chloridum hexahydricum, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml corresp. natrium 2.01 mg, kalium 0.08 mg, residui: cetrimidum, formaldehydum, gentamicini sulfas, polysorbatum 80, ovalbuminum. | | Packungsbestandteile | | | | Packungsnummer | Packungsgrösse | EFP | PP | Kat. | SL | In Refdata nicht gelistet |
|---|
| 011 | | PA | PA | B | | Nein | | 012 | 10 | PA | PA | B | | Nein |
|
|
